Why the study?
Does chemotherapy without irradiation affect final height in children with acute lymphoblastic leukemia?
Does chemotherapy without irradiation affect final height in children with acute lymphoblastic leukemia?
Children treated for acute lymphoblastic leukemia with chemotherapy alone experience catch-up growth resulting in normal final height and body proportions.
Answers are grounded in this paper and cite their sources.
May reassure on final height after chemo-only ALL therapy; hypothesis-generating and leaves generalizability open.
In order to evaluate the influence of chemotherapy on linear growth, 28 children treated for acute lymphoblastic leukemia without irradiation were evaluated before, during and after the end of therapy. Median age at diagnosis was 4.4 years (range 2.2-12.7 years) and treatment was discontinued after a median period of 3.1 years (3.0-5.2 years). We observed a significant decrease in height SDS (p = 0.006) from diagnosis to the end of chemotherapy, followed by catch-up in height SDS from the end of chemotherapy to final observation. Catch-up growth took place mainly within the first 2 years after cessation of therapy. In 22 patients final height was reached. Final height was normal (median height SDS -0.035) and even significantly higher than mid-parental height SDS (p = 0.012). In those patients who attained adult stature, the sitting height to standing height ratio was also normal. In conclusion, in children treated for acute lymphoblastic leukemia, chemotherapy exerted a negative influence on growth, but catch-up occurred within 2 years after cessation of therapy, resulting in normal final height and body proportions.
No takes yet. Share an insight, caveat, or question.
Holm et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: